Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × camrelizumab × Clear all

NCT05564897 2022-10-04

Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms